[Pharmacology of the new antihistaminic 9,9-dioxopromethazine (Prothanon)].
D000014:Abnormalities, Drug-Induced; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000517:prevention & control; D002302:Cardiac Output / Q000187:drug effects; D002339:Carotid Arteries; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003214:Conditioning, Classical / Q000187:drug effects; D003436:Croton Oil; D003864:Depression, Chemical; D004357:Drug Synergism; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D004622:Embryo, Mammalian / Q000187:drug effects; D004878:Ergotamine / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007082:Ileum / Q000187:drug effects; D008297:Male; D051379:Mice; D009184:Mydriatics / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D011398:Promethazine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D011506:Proteins; D011817:Rabbits; D051381:Rats; D012472:Salivation / Q000187:drug effects; D012702:Serotonin Antagonists
D000779:Anesthetics, Local; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D009184:Mydriatics; D010276:Parasympatholytics; D011506:Proteins; D012702:Serotonin Antagonists; D000431:Ethanol; D003436:Croton Oil; D010208:Papaverine; D011398:Promethazine; D004878:Ergotamine
Zur Pharmakologie des neuen Antihistaminicums 9.9-Dioxopromethazin (Prothanon)